1. Home
  2. QBTS vs XBIT Comparison

QBTS vs XBIT Comparison

Compare QBTS & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo D-Wave Quantum Inc.

QBTS

D-Wave Quantum Inc.

N/A

Current Price

$16.54

Market Cap

6.0B

Sector

Technology

ML Signal

N/A

Logo XBiotech Inc.

XBIT

XBiotech Inc.

N/A

Current Price

$2.20

Market Cap

66.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
QBTS
XBIT
Founded
1999
2005
Country
United States
United States
Employees
388
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Pharmaceuticals and Biotechnology
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.0B
66.8M
IPO Year
2022
2015

Fundamental Metrics

Financial Performance
Metric
QBTS
XBIT
Price
$16.54
$2.20
Analyst Decision
Strong Buy
Analyst Count
17
0
Target Price
★ $34.65
N/A
AVG Volume (30 Days)
★ 13.3M
36.5K
Earning Date
11-05-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$72.74
N/A
Revenue Next Year
$89.80
$30.47
P/E Ratio
★ N/A
N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$12.75
$2.09
52 Week High
$46.75
$3.44

Technical Indicators

Market Signals
Indicator
QBTS
XBIT
Relative Strength Index (RSI) 44.14 47.52
Support Level $12.75 $2.16
Resistance Level $19.01 $2.48
Average True Range (ATR) 0.88 0.04
MACD 0.04 0.01
Stochastic Oscillator 18.95 66.67

Price Performance

Historical Comparison
QBTS
XBIT

About QBTS D-Wave Quantum Inc.

D-Wave Quantum Inc is in the development and delivery of quantum computing systems, software, and services, and it is the commercial supplier of quantum computers and the only company building both annealing quantum computers and gate-model quantum computers. It delivers customer value with practical quantum applications for problems as diverse as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, cybersecurity, fault detection, and financial modeling. Its annealing quantum computers are accessible through the company's LeapTM cloud service.

About XBIT XBiotech Inc.

XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.

Share on Social Networks: